CD19 and autoimmune disease: Recently, case studies of patients with neuroinflammatory autoimmune diseases including stiff person syndrome and myasthenia gravis have also been treated successfully with the fully human, anti-CD19 CAR T-cell product, KYV-101, which contains the same CAR construct used in this study [20,22,27].